National Database for Autism Research (NDAR): Big Data Opportunities for Health Services Research and Health Technology Assessment

PharmacoEconomics

Volumn 34, Issue 2, 2016, Pages 127-138

  Payakachat, Nalin ^a   Tilford, J Mick ^a   Ungar, Wendy J ^b,c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTISM; BEHAVIOR THERAPY; BIOINFORMATICS; BIOMEDICAL TECHNOLOGY ASSESSMENT; CHILD; CLINICAL ARTICLE; CLOUD COMPUTING; COGNITIVE THERAPY; COMPUTER PROGRAM; DATA BASE; FEMALE; GLOBAL UNIQUE IDENTIFIER; HEALTH SERVICES RESEARCH; HUMAN; MALE; MEDICAL RESEARCH; MEDICAL TERMINOLOGY; NEUROIMAGING; OCCUPATIONAL THERAPY; PHYSIOTHERAPY; PLAY THERAPY; PRIORITY JOURNAL; SPECIAL EDUCATION; SPEECH THERAPY; AUTISTIC DISORDER; COOPERATION; FACTUAL DATABASE; INFORMATION DISSEMINATION; INFORMATION PROCESSING; MASS SCREENING; ORGANIZATION AND MANAGEMENT; PROCEDURES; UNITED STATES;

AUTISTIC DISORDER; CHILD; COOPERATIVE BEHAVIOR; DATA COLLECTION; DATABASES, FACTUAL; HEALTH SERVICES RESEARCH; HUMANS; INFORMATION DISSEMINATION; MASS SCREENING; TECHNOLOGY ASSESSMENT, BIOMEDICAL; UNITED STATES;

EID: 84958772422     PISSN: 11707690     EISSN: 11792027     Source Type: Journal    
DOI: 10.1007/s40273-015-0331-6     Document Type: Article

References (32)

1. Zerhouni E. Medicine. The NIH Roadmap. Science. 2003;302(5642):63–72.
2. Insel TR, Volkow ND, Landis SC, Li TK, Battey JF, Sieving P. Limits to growth: why neuroscience needs large-scale science. Nat Neurosci. 2004;7(5):426–7.
3. Westfall JM, Mold J, Fagnan L. Practice-based research–”Blue Highways” on the NIH roadmap. JAMA. 2007;297(4):403–6.
4. National Institutes of Health. National Database for Autism Research (NDAR). https://ndar.nih.gov/. Accessed 23 Apr 2015.
5. Hall D, Huerta M, McAuliffe M, Farber G. Sharing heterogeneous data: the National Database for Autism Research. Neuroinform. 2012;10(4):331–9.
6. Torgerson C, Quinn C, Dinov I, Liu Z, Petrosyan P, Pelphrey K, et al. Interacting with the National Database for Autism Research (NDAR) via the LONI Pipeline workflow environment. Brain Imaging Behav. 2015;9(1):89–103.
7. Di Martino A, Yan CG, Li Q, Denio E, Castellanos FX, Alaerts K, et al. The autism brain imaging data exchange: towards a large-scale evaluation of the intrinsic brain architecture in autism. Mol Psychiatry. 2014;19(6):659–67.
8. Johnson SB, Whitney G, McAuliffe M, Wang H, McCreedy E, Rozenblit L, et al. Using global unique identifiers to link autism collections. J Am Med Inform Assoc. 2010;17(6):689–95.
9. Luo XZ, Kennedy D, Cohen Z. Neuroimaging informatics tools and resources clearinghouse (NITRC) resource announcement. Neuroinform. 2009;7(1):55–6.
10. National Institutes of Health Blueprint for Neuroscience Research. NITRC Computational Environment. 2015. https://aws.amazon.com/marketplace/pp/B00AW0MBLO#product-details. Accessed 28 Apr 2015.
11. Iossifov I, O’Roak BJ, Sanders SJ, Ronemus M, Krumm N, Levy D, et al. The contribution of de novo coding mutations to autism spectrum disorder. Nature. 2014;515(7526):216–21.
12. Supekar K, Uddin L, Khouzam A, Phillips J, Gaillard W, Kenworthy L, et al. Brain hyperconnectivity in children with autism and its links to social deficits. Cell Rep. 2013;5(3):738–47.
13. Wei T, Chesnut S, Barnard-Brak L, Richman D. Psychometric analysis of the Social Communication Questionnaire using an item-response theory framework: implications for the use of the lifetime and current forms. J Psychopathol Behav Assess. 2015;37(3)469–80.
14. Payakachat N, Tilford JM, Kovacs E, Kuhlthau K. Autism spectrum disorders: a review of measures for clinical, health services and cost-effectiveness applications. Expert Rev Pharmacoecon Outcomes Res. 2012;12(4):485–503.
15. Payakachat N, Tilford JM, Kuhlthau KA, van Exel NJ, Kovacs E, Bellando J, et al. Predicting health utilities for children with autism spectrum disorders. Autism Res. 2014;7(6):649–63.
16. Lavelle TA, Weinstein MC, Newhouse JP, Munir K, Kuhlthau KA, Prosser LA. Economic burden of childhood autism spectrum disorders. Pediatrics. 2014;133(3):e520–9.
17. Penner M, Rayar M, Bashir N, Roberts SW, Hancock-Howard R, Coyte P. Cost-effectiveness analysis comparing pre-diagnosis autism spectrum disorder (ASD)-targeted intervention with Ontario’s Autism Intervention Program. J Autism Dev Disord. 2015;45(9):2833–47.
18. Wang L, Mandell DS, Lawer L, Cidav Z, Leslie DL. Healthcare service use and costs for autism spectrum disorder: a comparison between medicaid and private insurance. J Autism Dev Disord. 2013;43(5):1057–64.
19. Ungar WJ. Next generation sequencing and health technology assessment in autism spectrum disorder. J Can Acad Child Adolesc Psychiatry. 2015;24(2):123–7.
20. Dawson G, Rogers S, Munson J, Smith M, Winter J, Greenson J, et al. Randomized, controlled trial of an intervention for toddlers with autism: the Early Start Denver Model. Pediatrics. 2010;125(1):e17–23.
21. Webb SJ, Jones EJH, Kelly J, Dawson G. The motivation for very early intervention for infants at high risk for autism spectrum disorders. Int J Speech Lang Pathol. 2014;16(1):36–42.
22. Ontario Personalized Medicine Network Subcommittee Report. Evaluating our current health technology assessment capabilities in light of personalized medicine technologies. 2013. http://www.ontariogenomics.ca/personalized-medicine/personalized-medicine-resources. Accessed 15 Apr 2015.
23. Buchanan J, Wordsworth S, Schuh A. Issues surrounding the health economic evaluation of genomic technologies. Pharmacogenomics. 2013;14(15):1833–47.
24. Damiano CR, Mazefsky CA, White SW, Dichter GS. Future directions for research in autism spectrum disorders. J Clin Child Adolesc Psychol. 2014;43(5):828–43.
25. Coury DL, Swedo SE, Thurm AE, Miller DT, Veenstra-Vanderweele JM, Carbone PS, et al. Treating the whole person with autism: the proceedings of the autism speaks national autism conference. Curr Probl Pediatr Adolesc Health Care. 2014;44:26–47.
26. Mazefsky CA, Oswald DP, Day TN, Eack SM, Minshew NJ, Lainhart JE. ASD, a psychiatric disorder, or both? Psychiatric diagnoses in adolescents with high-functioning ASD. J Clin Child Adolesc Psychol. 2012;41:516–23.
27. Warren Z, McPheeters ML, Sathe N, Foss-Feig JH, Glasser A, Veenstra-Vanderweele J. A systematic review of early intensive intervention for autism spectrum disorders. Pediatrics. 2011;127(5):e1303–11.
28. Reichow B, Steiner AM, Volkmar F. Cochrane review: social skills groups for people aged 6 to 21 with autism spectrum disorders (ASD). Evid Based Child Health. 2013;8:266–315.
29. Taylor JL, McPheeters ML, Sathe NA, Dove D, Veenstra-Vanderweele J, Warren Z. A systematic review of vocational interventions for young adults with autism spectrum disorders. Pediatrics. 2012;130:531–8.
30. Casey BJ, Craddock N, Cuthbert BN, Hyman SE, Lee FS, Ressler KJ. DSM-5 and RDoC: progress in psychiatry research? Nat Rev Neurosci. 2013;14(11):810–4.
31. Easter Seals Florida, Inc. Treasure Coast Early Steps System of Care. Palm Beach, Martin, St. Lucie, Indian River and Okeechobee Counties. http://www.easterseals.com/florida/shared-components/document-library/tces-enrollment-packet-fy14/2014-17-tces-provider-1.pdf. Accessed 28 Aug 2015.
32. Early intervention service descriptions, billing codes and rates. Early intervention provided handbook. Illinois Department of Human Services, Community Health and Prevention, Bureau of Early Intervention; 1 Sep 2009. https://www.dhs.state.il.us/OneNetLibrary/27897/documents/Manuals/CHP/EI/EIServiceDescriptionManual.pdf. Accessed 28 Aug 2015.